新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
9期
597-600
,共4页
肖丽萍%毕向军%李亚南%余新沛%刘岗%杨明常%刘坚
肖麗萍%畢嚮軍%李亞南%餘新沛%劉崗%楊明常%劉堅
초려평%필향군%리아남%여신패%류강%양명상%류견
前列腺增生%三羟异黄酮%大鼠%体外
前列腺增生%三羥異黃酮%大鼠%體外
전렬선증생%삼간이황동%대서%체외
Benign prostate hyperplasia%Genistein%Mice%In vitro
目的:应用三羟异黄酮对 BPH 小鼠模型和体外培养的前列腺上皮细胞进行干预治疗,观察其对 BPH 治疗作用及对细胞的影响。方法选择32只雄性昆明小鼠,应用丙酸睾丸酮肌内注射制作小鼠 BPH 模型;然后分为4组,每组各8只小鼠。其中3组小鼠分别采用10、30、90 mg/(kg ·d)三羟异黄酮剂治疗4周,余1组为对照组,不予任何治疗。4周后处死4组小鼠,取前列腺称重,计算前列腺指数。另外取 BPH 患者前列腺上皮细胞加入不同培养孔,每孔2×104个细胞,分别应用含0、0.1、0.5、1.0、2.5、5.0μmol/L 三羟异黄酮的培养基培养10 d 后收集各组细胞,染色并计数,比较6组细胞的活率。结果治疗4周后,3组实验组小鼠前列腺质量均低于对照组(P <0.05),中、高剂量组小鼠前列腺指数低于对照组(P <0.05)。应用0、0.1、0.5、1.0、2.5、5.0μmol/L 三羟异黄酮处理的前列腺上皮细胞数分别为(4.71±0.78)×104个、(4.46±1.15)×104个、(3.84±1.33)×104个、(2.01±0.31)×104个、(0.58±0.28)×104个、(0.20±0.12)×104个;台盼蓝染色提示各组前列腺上皮细胞活率分别为99.3%、98.7%、96.7%、93.3%、90.7%、88.7%,1.0、2.5、5.0μmol/L 组上皮细胞数少于对照组,细胞活率亦明显低于对照组(P <0.05或0.01)。结论三羟异黄酮可减轻 BPH 小鼠模型的前列腺质量,对前列腺上皮细胞增殖有抑制作用。
目的:應用三羥異黃酮對 BPH 小鼠模型和體外培養的前列腺上皮細胞進行榦預治療,觀察其對 BPH 治療作用及對細胞的影響。方法選擇32隻雄性昆明小鼠,應用丙痠睪汍酮肌內註射製作小鼠 BPH 模型;然後分為4組,每組各8隻小鼠。其中3組小鼠分彆採用10、30、90 mg/(kg ·d)三羥異黃酮劑治療4週,餘1組為對照組,不予任何治療。4週後處死4組小鼠,取前列腺稱重,計算前列腺指數。另外取 BPH 患者前列腺上皮細胞加入不同培養孔,每孔2×104箇細胞,分彆應用含0、0.1、0.5、1.0、2.5、5.0μmol/L 三羥異黃酮的培養基培養10 d 後收集各組細胞,染色併計數,比較6組細胞的活率。結果治療4週後,3組實驗組小鼠前列腺質量均低于對照組(P <0.05),中、高劑量組小鼠前列腺指數低于對照組(P <0.05)。應用0、0.1、0.5、1.0、2.5、5.0μmol/L 三羥異黃酮處理的前列腺上皮細胞數分彆為(4.71±0.78)×104箇、(4.46±1.15)×104箇、(3.84±1.33)×104箇、(2.01±0.31)×104箇、(0.58±0.28)×104箇、(0.20±0.12)×104箇;檯盼藍染色提示各組前列腺上皮細胞活率分彆為99.3%、98.7%、96.7%、93.3%、90.7%、88.7%,1.0、2.5、5.0μmol/L 組上皮細胞數少于對照組,細胞活率亦明顯低于對照組(P <0.05或0.01)。結論三羥異黃酮可減輕 BPH 小鼠模型的前列腺質量,對前列腺上皮細胞增殖有抑製作用。
목적:응용삼간이황동대 BPH 소서모형화체외배양적전렬선상피세포진행간예치료,관찰기대 BPH 치료작용급대세포적영향。방법선택32지웅성곤명소서,응용병산고환동기내주사제작소서 BPH 모형;연후분위4조,매조각8지소서。기중3조소서분별채용10、30、90 mg/(kg ·d)삼간이황동제치료4주,여1조위대조조,불여임하치료。4주후처사4조소서,취전렬선칭중,계산전렬선지수。령외취 BPH 환자전렬선상피세포가입불동배양공,매공2×104개세포,분별응용함0、0.1、0.5、1.0、2.5、5.0μmol/L 삼간이황동적배양기배양10 d 후수집각조세포,염색병계수,비교6조세포적활솔。결과치료4주후,3조실험조소서전렬선질량균저우대조조(P <0.05),중、고제량조소서전렬선지수저우대조조(P <0.05)。응용0、0.1、0.5、1.0、2.5、5.0μmol/L 삼간이황동처리적전렬선상피세포수분별위(4.71±0.78)×104개、(4.46±1.15)×104개、(3.84±1.33)×104개、(2.01±0.31)×104개、(0.58±0.28)×104개、(0.20±0.12)×104개;태반람염색제시각조전렬선상피세포활솔분별위99.3%、98.7%、96.7%、93.3%、90.7%、88.7%,1.0、2.5、5.0μmol/L 조상피세포수소우대조조,세포활솔역명현저우대조조(P <0.05혹0.01)。결론삼간이황동가감경 BPH 소서모형적전렬선질량,대전렬선상피세포증식유억제작용。
Objective To observe the effect of genistein on benign prostate hyperplasia (BPH)in mice and human prostatic epithelial cells (HPEC)in vitro.Methods Thirty-two Kunming mice were injected with testosterone to establish BPH models and then were divided into four groups.In three treatment groups, mice were given with different doses of genistein (1 0,30,90 mg/(kg·d))for four weeks and the mice in the control group were not treated.Then,the mice were sacrificed,the prostates were weighed and the prostate index was calculated.HPECs isolated from prostatectomy specimens of BPH patients were inoculated with cul-ture media containing 0.1 ,0.5,1 .0,2.5,5.0 μmol/L of genistein for 1 0 days,trypsinized and then counted with a hemocytometer.Results The weights of prostate in mice treated with genistein were lower than that of control group (P <0.05).Prostate indexes of middle and high dose group were lower than that of control group (P <0.05).The number of HPECs treaded with 0,0.1 ,0.5,1 .0,2.5,5.0 μmol/L of genistein was (4.71 ±0.78) ×1 04、(4.46 ±1 .1 5) ×1 04、(3.84 ±1 .33) ×1 04 ,(2.01 ±0.31 ) ×1 04 ,(0.58 ±0.28) × 1 04 and (0.20 ±0.1 2) ×1 04.Trypan blue staning revealed that the percentage of living cells was 99.3%, 98.7%,96.7%,93.3%,90.7% and 88.7%.Conclusion Genistein can suppress the growth of HEPCs and mitigate BPH induced by testosterone.